Health Care Select Sector... (XLV)
| Bid | 136.72 |
| Market Cap | 33.39B |
| AUM | 32.71B |
| NAV | 133.94 |
| EPS (ttm) | 5.53 |
| PE Ratio (ttm) | 24.71 |
| Shares Out | 244.22M |
| Inception Date | Dec 16, 1998 |
| Ask | 136.78 |
| Volume | 13.22M |
| Open | 135.87 |
| Previous Close | 135.89 |
| Day's Range | 135.78 - 137.22 |
| 52-Week Range | 127.35 - 159.64 |
| Holdings | 60 |
| Expense Ratio | 0.08% |
About XLV
The Health Care Select Sector SPDR Fund seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the Health Care Select Sector Index (the “Index”).The Index seeks to provide an effective representation of the health care sector of the S&P 500 Index.Seeks to provide precise exposure to companies in the pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and health care technology industries.Allows investors to take strategic or tactical positions at a more targeted level than traditional style based investing.
Top 10 Holdings 54.82% of assets
| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly And Compan... | LLY | 11.06% |
| Johnson & Johnson | JNJ | 8.66% |
| Abbvie Inc. | ABBV | 7.45% |
| Unitedhealth Group I... | UNH | 5.07% |
| Abbott Laboratories | ABT | 4.63% |
| Merck & Co., Inc. | MRK | 4.28% |
| Thermo Fisher Scient... | TMO | 3.77% |
| Intuitive Surgical, ... | ISRG | 3.52% |
| Amgen Inc. | AMGN | 3.21% |
| Boston Scientific Co... | BSX | 3.17% |
Dividends Dividend Yield 1.81%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Jun 23, 2025 | $0.6304 | Jun 25, 2025 |
| Mar 24, 2025 | $0.5645 | Mar 26, 2025 |
| Dec 23, 2024 | $0.6217 | Dec 26, 2024 |
| Sep 23, 2024 | $0.5772 | Sep 25, 2024 |
| Jun 24, 2024 | $0.5725 | Jun 26, 2024 |
1 month ago · seekingalpha.com
XLV: Life Expectancy, Patents, And A Positive Outlook Will Pave The WayThe life expectancy has increased in the U.S. and worldwide, contributing to healthcare companies retaining their patients for longer periods. Investors pay low fees to hold XLV, since the expense rat...
